UroGen Pharma Ltd. - Ordinary Shares (URGN): Price and Financial Metrics
URGN Price/Volume Stats
Current price | $10.56 | 52-week high | $20.70 |
Prev. close | $10.77 | 52-week low | $9.78 |
Day low | $10.54 | Volume | 206,500 |
Day high | $11.09 | Avg. volume | 349,832 |
50-day MA | $10.91 | Dividend yield | N/A |
200-day MA | $13.18 | Market Cap | 247.67M |
URGN Stock Price Chart Interactive Chart >
UroGen Pharma Ltd. - Ordinary Shares (URGN) Company Bio
UroGen Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing therapies for urological pathologies. The company is developing its product candidates as chemoablation agents, which are designed to remove tumors by non-surgical means, to treat several forms of non-muscle invasive urothelial cancer, including low-grade upper tract urothelial carcinoma, and low-grade bladder cancer. The company was founded in 2004 and is based in Raanana, Israel.
URGN Price Returns
1-mo | N/A |
3-mo | -8.57% |
6-mo | -25.42% |
1-year | -45.11% |
3-year | 71.99% |
5-year | -65.13% |
YTD | -0.85% |
2024 | -29.00% |
2023 | 69.11% |
2022 | -6.73% |
2021 | -47.23% |
2020 | -46.00% |
Loading social stream, please wait...